 oncoGenex Pharmaceuticals is a biopharmaceutical company that is focused on the development and commercialization of novel therapies for the treatment of cancer. 
 we have two lead product candidates, Custirsen and Apatorsen, which are designed to inhibit the production of serum heat shock protein 27. 
 we provide an update on our clinical programs and preview anticipated milestones through the end of this year and into 2016.    
 # 1_#1 _ # 1_#1 _ =    # 1 1.25 in.125 in.25 in 